cardiac diseases
Conditions
Interventions
None listed
Sponsors
Kagoshima University Hospital
Kagoshima Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with cardiac surgery.
Exclusion criteria
Exclusion criteria: Patients with dialysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vascular endothelial growth factor (VEGF) in serum: From just before cardiac surgery to one month after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| MicroRNAs in serum and platelets. IL-6 and thrombopoietin (TPO) in serum.C-reactive protein (CRP) and Brain natriuretic peptide (BNP) in serum. | — |
Countries
Japan
Contacts
Public ContactTeruto Hashiguchi
Kagoshima University Graduate School of Medical and Dental Sciences Department of Laboratory and Vascular Medicine
Outcome results
None listed